| Authors: |
Blaye C; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France., Darbo É; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Brouste V; Departments of Clinical Research and Medical Information, Bordeaux, France., Vélasco V; Biopathology, Institut Bergonié, Bordeaux, France., Pinard C; Pathology Laboratory, University Hospital of Martinique, Fort de France., Larmonier N; Univ. Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France; Univ. Bordeaux, Bordeaux, France., Pellegrin I; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France; Centre de Ressources Biologiques Plurithématique, University Hospital of Bordeaux, Bordeaux, France., Tarricone A; Service d'Immunologie et Immunogénétique, University Hospital of Bordeaux, Bordeaux, France., Arnedos M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Commeny J; Department of Surgery, Institut Bergonié, Bordeaux, France., Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Bordeaux, France; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Univ. Bordeaux, Bordeaux, France., Larmonier C; Biopathology, Institut Bergonié, Bordeaux, France., MacGrogan G; Univ. Bordeaux, INSERM U1218, ACTION Laboratory, Bordeaux, France; Biopathology, Institut Bergonié, Bordeaux, France. Electronic address: g.macgrogan@bordeaux.unicancer.fr. |